Primary immunodeficiency masks: A clinical case of vaccine-associated paralytic poliomyelitis
- Authors: Savin T.V.1,2, Kuznetsova R.N.1,3, Kuznetsova A.A.2, Totolian A.A.1,3
-
Affiliations:
- First St. Petersburg State I. Pavlov Medical University
- St. Petersburg State Pediatric Medical University
- St. Petersburg Pasteur Institute
- Issue: Vol 23, No 4 (2020)
- Pages: 499-504
- Section: SHORT COMMUNICATIONS
- Submitted: 26.10.2020
- Accepted: 26.10.2020
- Published: 15.10.2020
- URL: https://rusimmun.ru/jour/article/view/950
- DOI: https://doi.org/10.46235/1028-7221-398-PMI
- ID: 950
Cite item
Full Text
Abstract
Human inborn immune-related errors comprise a heterogeneous group of rare genetically determined diseases of the immune system caused by loss or gain of function mutations altering relevant protein functions. The 2019 International Union of Immunological Societies recently proposed the classification for such pathologies now comprising 406 distinct disorders with 430 different gene defects. Predominantly antibody deficiencies represent most common group of human inborn immune-related errors, which diagnostics poses uneasy challenge for general practitioner due to a broad range of their clinical manifestations, such as infection, allergy, autoimmunity and malignancy. In addition, patients with human immune-related inborn errors may develop a vaccine-associated disease after administering live vaccines in accordance with the Russia-wide National Vaccine Schedule. Most common among vaccine-associated diseases are vaccine-associated paralytic poliomyelitis, vaccine-associated encephalitis (1 case per 1 000 000 doses of measles, rubella, varicella vaccine), vaccine-associated meningitis (1 case per 250 000 – 500 000 doses of mumps vaccine) as well as adverse effects related to BCG immunization: local (infiltration, cold abscess – 8.6 case per 100,000 vaccinated patients) and disseminated complications (BCG lymphadenitis – 15.5 case per 100 000 vaccinated patients, BCG osteitis – 3.5 case per 100 000 vaccinated patients). Vaccine-associated paralytic poliomyelitis in vaccinated patients occurs after the first, second and rarely third oral polio vaccine dose inoculation. Incidence rate for vaccineassociated paralytic polio after 1 and 3 oral vaccine inoculation ranges from 1 case per 700 000 vaccine doses to 1 case per 3 500 000, respectively. Vaccine-associated paralytic poliomyelitis mainly emerges due to inborn mutations related to humoral immunity after primary vaccination with oral polio vaccine or close contact of unvaccinated patients with subjects vaccinated with oral polio vaccine. Here, we describe a clinical case of vaccine-associated paralytic poliomyelitis in patient with primary immunodeficiency. Our is aimed at emphasizing importance of immunological alertness with regard to detecting primary immunodeficiencies and timely apply a replacement therapy prior to verifying type of immunodeficiency.
About the authors
T. V. Savin
First St. Petersburg State I. Pavlov Medical University; St. Petersburg State Pediatric Medical University
Author for correspondence.
Email: savintihon@gmail.com
Savin Tikhon V. - Senior Laboratory Assistant, Department of Immunology; Resident, I. Vorontsov Department of Childhood Diseases
194017, St. Petrsburg, Torez ave., 102, bldg 5, apt 40
Phone: 7 (911) 288-39-74
Russian FederationR. N. Kuznetsova
First St. Petersburg State I. Pavlov Medical University; St. Petersburg Pasteur Institute
Email: fake@neicon.ru
PhD (Medicine), Associate Professor, Department of Immunology; Allergist-Immunologist, Medical Centre
St. Petersburg
Russian FederationA. A. Kuznetsova
St. Petersburg State Pediatric Medical University
Email: fake@neicon.ru
PhD, MD (Medicine), Professor, Department of Faculty Pediatrics
St. Petersburg
Russian FederationAreg A. Totolian
First St. Petersburg State I. Pavlov Medical University; St. Petersburg Pasteur Institute
Email: fake@neicon.ru
PhD, MD (Medicine), Professor, Full Member, Russian Academy of Sciences, Head, Department of Immunology; Director
St. Petersburg
Russian FederationReferences
- Иванова О.Е., Еремеева Т.П., Морозова Н.С., Шакарян А.К., Гмыль А.П., Яковенко М.Л., Короткова Е.А., Чернявская О.П., Байкова О.Ю., Силенова О.В., Красота А.Ю., Краснопрошина Л.И., Мустафина А.Н., Козловская Л.И. Вакциноассоциированный паралитический полиомиелит в Российской Федерации в период изменения схемы вакцинации (2006-2013 гг.) // Вопросы вирусологии, 2016. Т. 61, № 1. С. 9-15. [Ivanova O.E., Eremeeva T.P., Morozova N.S., Shakaryan A.K., Gmyl A.P., Yakovenko M.L., Korotkova E.A., Chernjavskaja O.P., Baykova O.Yu., Silenova O.V., Krasota A.Yu., Krasnoproshina L.I., Mustafina A.N., Kozlovskaja L.I. Vaccine-associated paralytic poliomyelitis in Ru ssian Federation during the period of changes in vaccination schedule (2006-2013 years). Voprosy virusologii = Problems of Virology, 2016, Vol. 61, no. 1, pp. 9-15. (In Russ.)]
- Шакарян А.К., Таточенко В.К., Иванова О.Е., Mорозова Н.С., Чернявская О.П., Еремеева Т.П., Козловская Л.И., Михайлова Ю.М., Еровиченков А.А. Клиническая характеристика случаев вакциноассоциированного паралитического полиомиелита в Российской Федерации в 2006-2016 гг. // Инфекционные болезни, 2019. Т. 17, № 1. С. 115-123. [Shakaryan A.K., Tatochenko V.K., Ivanova O.E., Morozova N.S., Chernyavskaya O.P., Eremeeva T.P., Kozlovskaya L.I., Mikhailova Yu.M., Erovichenkov A.A. Clinical characteristics of cases of vaccine-associated paralytic polio documented in the Russian Federation in 2006-2016. Infektsionnye bolezni = Infectious Diseases, 2019, Vol. 17, no. 1, pp. 115-123. (In Russ.)]
- Bousfiha A., Jeddane L., Picard C., Al-Herz W., Ailal F., Chatila T., Cunningham-Rundles C., Etzioni A., Franco J.L., Holland S.M., Klein C., Morio T., Ochs H.D., Oksenhendler E., Puck J., Torgerson T.R., Casanova J.-L., Sullivan K.E., Tangye S.G. Human inborn errors of immunity: 2019 update of the IUIS phenotypical classification. J. Clin. Immunol., 2020, Vol. 40, no. 1, pp. 66-81.